Echinococcus granulosus infection: Clinical presentation, medical treatment and outcome

Langenbeck's Archives of Surgery

Volumn 388, Issue 6, 2003, Pages 413-420

  Kern, Peter ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Benzimidazoles; Clinical presentation; Cystic echinococcosis; Echinococcus granulosus; Hydatid disease; Medical treatment; Review

Indexed keywords

ALBENDAZOLE; AMINOTRANSFERASE; MEBENDAZOLE; PRAZIQUANTEL;

ALOPECIA; AMINOTRANSFERASE BLOOD LEVEL; ASPIRATION; CLINICAL FEATURE; CLINICAL TRIAL; CONSERVATIVE TREATMENT; DISEASE COURSE; DOSE RESPONSE; DRUG EFFICACY; DRUG EXCRETION; DRUG MARKETING; ECHINOCOCCOSIS; ECHINOCOCCUS GRANULOSUS; HUMAN; INJECTION; LEUKOPENIA; LIVER DYSFUNCTION; PRIORITY JOURNAL; RELAPSE; REVIEW; SERODIAGNOSIS; TERATOGENICITY;

ALBENDAZOLE; ANIMALS; ANTHELMINTICS; DIAGNOSTIC IMAGING; ECHINOCOCCOSIS; ECHINOCOCCOSIS, HEPATIC; FEMALE; HUMANS; MALE; MEBENDAZOLE; PRAZIQUANTEL; TREATMENT OUTCOME;

EID: 0345530024     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00423-003-0418-y     Document Type: Review

References (42)

1. Eckert J, Schantz PM, Gasser RB, Torgerson PR, Bessonov AS, Movsessian SO, Thakur A, Grimm F, Nikogossian MA (2001) Geographic distribution and prevalence. In: Eckert J, et al. (eds) WHO/OIE manual on echinococcosis in humans and animals: a public health problem of global concern. pp 100-142
2. Pawlowski ZS, Eckert J, Vuitton DA Ammann RW, Kern P, Craig PS, Kar F, De Rosa F, Filice C, Gottstein B, Grimm F, Macpherson CNL, Sato N, Todorov T, Uchino J, von Sinner W, Wen H (2001) Echinococcosis in humans: clinical aspects, diagnosis and treatment. In: Eckert J, et al. (eds) WHO/OIE manual on echinococcosis in humans and animals: a public health problem of global concern. pp 20-71
3. World Health Organization (WHO) (2001) Puncture aspiration injection reaspiration-an option for the treatment of cystic echinococcosis. WHO-Informal Working Group on Echinococcosis (WHO-IWGE), WHO/CDS/CSR/APH/2001.6
4. World Health Organization (WHO) (1996) Guidelines for treatment of cystic and alveolar echinococcosis. WHO Informal Working Group on Echinococcosis. Bull WHO 74:231-242
5. Thompson RCA, McManus DP (2001) Aetiology: parasites and life-cycles. In: Eckert J, et al. (eds) WHO/OIE manual on echinococcosis in humans and animals: a public health problem of global concern. pp 1-19
6. Ammann RW, Eckert J (1996) Cestodes: Echinococcus. Gastroenterol Clin N Am 25:655-689
7. Pawlowski ZS (1997) Terminology related to Echinococcus and echinococcosis. Acta Trop 67:1-5
8. Ramos G, Orduna A, Garcia-Yuste M (2001) Hydatid cyst of the lung: diagnosis and treatment. World J Surg 25:46-57
9. von Sinner WN (1991) New diagnostic signs in hydatid disease; radiography, ultrasound, CT and MRI correlated to pathology. Eur J Radiol 12:150-159
10. Gharbi HA, Hassine W, Brauner MW, Dupuch K (1981) Ultrasound examination of the hydatid liver. Radiology 139:459-463
11. Siles-Lucas MM, Gottstein B (2001) Molecular tools for the diagnosis of cystic and alveolar echinococcosis. Trop Med Int Health 6:463-475
12. Dixon JB, Jenkins P (1995) Immunology of mammalian metacestode infections. II. Immune recognition and effector function. Helminth Abstr 64:599-613
13. Robert Koch Institute (RKI)(2003) Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2002. Robert Koch Institut, Berlin, pp 51-52
14. Spruance SL (1974) Latent period of 53 years in a case of hydatid cyst disease. Arch Int Med 134:741-742
15. Frider B, Larrieu E, Odrizola M (1999) Long-term outcome of asymptomatic liver hydatidosis. J Hepatol 30:228-231
16. Keshmiri M, Baharvahdat H, Fattahi SH, Davachi B, Dabiri RH, Baradaran H, Rajabzadeh F (2001) Albendazole versus placebo in treatment of echinococcosis. Trans R Soc Trop Med Hyg 95:190-194
17. Campbell WC (1990) Benzimidazoles: veterinary uses. Parasitol Today 6:130-133
18. Scholar EM, Pratt WB (2000) The antimicrobial drugs, 2nd edn. Oxford University Press
19. Lacey E (1990) Mode of action of benzimidazoles. Parasitol Today 6:112-115
20. Campbell WC, Blair LS (1974) Treatment of the cystic stage of Taenia crassiceps and Echinococcus multilocularis in the laboratory animals. J Parasitol 60:1053-1054
21. Eckert J, Barandun G, Pohlenz J (1978) Chemotherapie der larvalen Echinokokkose bei Labortieren. Schweiz Med Wochenschr 108:1104-1112
22. Bekhti A, Schaaps JP, Capron M, Dessaint JP, Santoro F, Capron A (1977) Treatment of hepatic hydatid disease with mebendazole: preliminary results in 4 cases. Br Med J 2:1047-1051
23. Kern P, Dietrich M, Volkmer KF (1979) Chemotherapy of echinococcosis with mebendazole: clinical observations of 7 patients. Tropenmed Parasitol 30:65-72
24. Ammann R, Akovbiantz A, Eckert J (1979) Chemotherapie der Echinokokkose des Menschen mit Mebendazole (Vermox). Schweiz Med Wochenschr 109:148-151
25. Schantz PM, van den Bosche H, Eckert J (1982) Chemotherapy of larval echinococcosis in animals and humans: report of a workshop. Z Parasitenkd 67:5-26
26. Morris DL, Dykes PW, Marriner SE, Bogan JA, Burrows FG (1983) Albendazole in hydatid disease. Br Med J 286:103-104
27. Saimot AG, Meulemans AC, Cremieux MD, Giovenangeli MD, Hay JM, Delaitre P (1983) Albendazole as a potential treatment for human hydatidosis. Lancet 2:652-656
28. Horton RJ (1989) Chemotherapy of Echinococcus infection in man with albendazole. Trans R Soc Trop Med Hyg 83:97-102
29. Horton RJ (1997) Albendazole in treatment of human cystic echinococcosis: 12 years of experience. Acta Trop 64:79-93
30. King CH, Mahmoud AAF (1989) Drugs five years later: praziquantel. Ann Int Med 110:290-296
31. Thompson RCA, Reynolds JA, Riddler CR (1986) Praziquantel adversely affects protoscolices of Echinococcus granulosus in vitro. J Helminthol 60:279-286
32. Gemmell MA, Parmeter SN (1983) Effects of praziquantel against eggs of Taenia hydatigena and protoscolices and metacestodes of Echinococcus granulosus. Vet Med Rev 1:3-9
33. Urrea-Paris MA, Moreno MJ, Casado N, Rodriquez-Caabeiro F (1999) Echinococcus granulosus: praziquantel treatment against the metacestode stage. Parasitol Res 85:999-1006
34. Cobo F, Yarnoz C, Sesma B, Fraile P, Aizcorbe M, Trujillo R, Diaz-de-Liano A, Ciga MA (1998) Albendazole plus praziquantel versus albendazole alone as a pre-operative treatment in intraabdominal hydatidosis caused by Echinococcus granulosus. Trop Med Int Health 3:462-466
35. Davis A, Pawlowski Z, Dixon H (1986) Multicenter clinical trials of benzimidazole-carbamates in human echinococcosis. Bull WHO 64:383-388
36. Davis A, Dixon H, Pawlowski Z (1989) Multicenter clinical trials of benzimidazole-carbarnates in human echinococcosis (phase 2). Bull WHO 67:503-508
37. Todorov T, Vutova K, Mechkov G, Georgiev P, Getkov D Tonchev Z, Nedelkov G (1992) Therapy of human hydatid disease with mebendazole and albendazole. Antimicrob Agents Chemother 37:164-167
38. Saimot AG (2001) Medical treatment of liver hydatidosis. World J Surg 25:15-20
39. Teggi A, Lastilla MG, De Rosa M (1993) Therapy of human hydatid disease with mebendazole and albendazole. Antimicrob Agents Chemother 37:1679-1684
40. Franchi C, Di Vico B, Teggi (1999) Long-term evaluation of patients with hydatidosis treated with benzimidazole carbarnates. Clin Infect Dis 29:304-309
41. Gil-Grande, et al. (1993) Randomized controlled trial of efficacy of albendazole in intra-abdominal hydatid disease. Lancet 342:1269-1272
42. Keshmiri M, Baharvahdat H, Fattahi SH, Davachi B, Dabiri RH, Baradan H, Ghiasi T, Rajabimashhadi MT, Rajabzadeh F (1999) A controlled study assessing the effects of albendazole in treatment of pulmonary echinococcosis. Eur Respir J 14:503-507